David Bench - Net Worth and Insider Trading
David Bench Net Worth
The estimated net worth of David Bench is at least $10,544 dollars as of 2024-05-02. David Bench is the CFO of Enzo Biochem Inc and owns about 10,138 shares of Enzo Biochem Inc (ENZ) stock worth over $10,544. Details can be seen in David Bench's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Bench has not made any transactions after 2022-06-14 and currently still holds the listed stock(s).
Transaction Summary of David Bench
David Bench Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Bench owns 1 companies in total, including Enzo Biochem Inc (ENZ) .
Click here to see the complete history of David Bench’s form 4 insider trades.
Insider Ownership Summary of David Bench
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ENZ | Enzo Biochem Inc | 2022-06-14 | CHIEF FINANCIAL OFFICER |
David Bench Latest Holdings Summary
David Bench currently owns a total of 1 stock. David Bench owns 10,138 shares of Enzo Biochem Inc (ENZ) as of June 14, 2022, with a value of $10,544.
Latest Holdings of David Bench
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ENZ | Enzo Biochem Inc | 2022-06-14 | 10,138 | 1.04 | 10,544 |
Holding Weightings of David Bench
David Bench Form 4 Trading Tracker
According to the SEC Form 4 filings, David Bench has made a total of 1 transactions in Enzo Biochem Inc (ENZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enzo Biochem Inc is the acquisition of 3,500 shares on June 14, 2022, which cost David Bench around $7,525.
Insider Trading History of David Bench
- 1
David Bench Trading Performance
GuruFocus tracks the stock performance after each of David Bench's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Bench is 4.76%. GuruFocus also compares David Bench's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Bench within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Bench's insider trading performs compared to the benchmark.
Performance of David Bench
David Bench Ownership Network
Ownership Network List of David Bench
Ownership Network Relation of David Bench
David Bench Owned Company Details
What does Enzo Biochem Inc do?
Who are the key executives at Enzo Biochem Inc?
David Bench is the CHIEF FINANCIAL OFFICER of Enzo Biochem Inc. Other key executives at Enzo Biochem Inc include 10 percent owner James G. Wolf , Chief Executive Officer Hamid Erfanian , and Interim CFO Patricia Eckert .
Enzo Biochem Inc (ENZ) Insider Trades Summary
Over the past 18 months, David Bench made no insider transaction in Enzo Biochem Inc (ENZ). Other recent insider transactions involving Enzo Biochem Inc (ENZ) include a net purchase of 26,800 shares made by James G. Wolf , and a net purchase of 100,000 shares made by Hamid Erfanian .
In summary, during the past 3 months, insiders sold 0 shares of Enzo Biochem Inc (ENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzo Biochem Inc (ENZ) were sold and 126,800 shares were bought by its insiders, resulting in a net purchase of 126,800 shares.
Enzo Biochem Inc (ENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzo Biochem Inc Insider Transactions
David Bench Mailing Address
Above is the net worth, insider trading, and ownership report for David Bench. You might contact David Bench via mailing address: Enzo Biochem, Inc., 527 Madison Avenue, New York Ny 10022.